Captopril restores transforming growth factor-β type II receptor and sensitivity to transforming growth factor-β in murine renal cell cancer cells

Akira Miyajima, Tomohiko Asano, Masamichi Hayakawa

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Purpose: Captopril is known to inhibit the growth of renal cancer but the mechanism involved has been unclear. The current study elucidates the mechanism of captopril induced inhibition of the growth of the Renca mouse renal cancer cell line involving transforming growth factor-β, which is known to be a growth inhibitory cytokine in epithelial cells and tissues. Materials and Methods: Transforming growth factor-β in conditioned medium was measured by bioassay. Levels of transforming growth factor-β and transforming growth factor-β type II receptor expression messenger RNA were determined by reverse transcriptase-polymerase chain reaction and flow cytometry. Cell viability was determined by bromodeoxyuridine (BrdU) incorporation and tetrazolium bromide assay. Results: Captopril (0.01 to 1 mM.) showed no significant effect on transforming growth factor-β synthesis or transforming growth factor-β messenger RNA in Renca cells. On the other hand, 1 mM. captopril significantly inhibited Renca cell growth. Reverse transcriptase-polymerase chain reaction and flow cytometry showed that 1 mM. captopril up-regulated type II receptor expression. Conclusions: These findings suggest that captopril restores transforming growth factor-β type II receptor expression and inhibits the growth of Renca cells by increasing their sensitivity to transforming growth factor-β.

Original languageEnglish
Pages (from-to)616-620
Number of pages5
JournalJournal of Urology
Volume165
Issue number2
DOIs
Publication statusPublished - 2001
Externally publishedYes

Fingerprint

Growth Factor Receptors
Captopril
Transforming Growth Factors
Renal Cell Carcinoma
Growth
Kidney Neoplasms
Reverse Transcriptase Polymerase Chain Reaction
Flow Cytometry
Messenger RNA
Bromodeoxyuridine
Conditioned Culture Medium
Bromides
Biological Assay
Cell Survival
Epithelium
Epithelial Cells
Cytokines
Cell Line

Keywords

  • Captopril
  • Carcinoma
  • Kidney
  • Mice
  • Receptors
  • Renal cell
  • Transforming growth factor beta

ASJC Scopus subject areas

  • Urology

Cite this

Captopril restores transforming growth factor-β type II receptor and sensitivity to transforming growth factor-β in murine renal cell cancer cells. / Miyajima, Akira; Asano, Tomohiko; Hayakawa, Masamichi.

In: Journal of Urology, Vol. 165, No. 2, 2001, p. 616-620.

Research output: Contribution to journalArticle

@article{ab6abb34f15b4504b085ad66767b0f42,
title = "Captopril restores transforming growth factor-β type II receptor and sensitivity to transforming growth factor-β in murine renal cell cancer cells",
abstract = "Purpose: Captopril is known to inhibit the growth of renal cancer but the mechanism involved has been unclear. The current study elucidates the mechanism of captopril induced inhibition of the growth of the Renca mouse renal cancer cell line involving transforming growth factor-β, which is known to be a growth inhibitory cytokine in epithelial cells and tissues. Materials and Methods: Transforming growth factor-β in conditioned medium was measured by bioassay. Levels of transforming growth factor-β and transforming growth factor-β type II receptor expression messenger RNA were determined by reverse transcriptase-polymerase chain reaction and flow cytometry. Cell viability was determined by bromodeoxyuridine (BrdU) incorporation and tetrazolium bromide assay. Results: Captopril (0.01 to 1 mM.) showed no significant effect on transforming growth factor-β synthesis or transforming growth factor-β messenger RNA in Renca cells. On the other hand, 1 mM. captopril significantly inhibited Renca cell growth. Reverse transcriptase-polymerase chain reaction and flow cytometry showed that 1 mM. captopril up-regulated type II receptor expression. Conclusions: These findings suggest that captopril restores transforming growth factor-β type II receptor expression and inhibits the growth of Renca cells by increasing their sensitivity to transforming growth factor-β.",
keywords = "Captopril, Carcinoma, Kidney, Mice, Receptors, Renal cell, Transforming growth factor beta",
author = "Akira Miyajima and Tomohiko Asano and Masamichi Hayakawa",
year = "2001",
doi = "10.1097/00005392-200102000-00083",
language = "English",
volume = "165",
pages = "616--620",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Captopril restores transforming growth factor-β type II receptor and sensitivity to transforming growth factor-β in murine renal cell cancer cells

AU - Miyajima, Akira

AU - Asano, Tomohiko

AU - Hayakawa, Masamichi

PY - 2001

Y1 - 2001

N2 - Purpose: Captopril is known to inhibit the growth of renal cancer but the mechanism involved has been unclear. The current study elucidates the mechanism of captopril induced inhibition of the growth of the Renca mouse renal cancer cell line involving transforming growth factor-β, which is known to be a growth inhibitory cytokine in epithelial cells and tissues. Materials and Methods: Transforming growth factor-β in conditioned medium was measured by bioassay. Levels of transforming growth factor-β and transforming growth factor-β type II receptor expression messenger RNA were determined by reverse transcriptase-polymerase chain reaction and flow cytometry. Cell viability was determined by bromodeoxyuridine (BrdU) incorporation and tetrazolium bromide assay. Results: Captopril (0.01 to 1 mM.) showed no significant effect on transforming growth factor-β synthesis or transforming growth factor-β messenger RNA in Renca cells. On the other hand, 1 mM. captopril significantly inhibited Renca cell growth. Reverse transcriptase-polymerase chain reaction and flow cytometry showed that 1 mM. captopril up-regulated type II receptor expression. Conclusions: These findings suggest that captopril restores transforming growth factor-β type II receptor expression and inhibits the growth of Renca cells by increasing their sensitivity to transforming growth factor-β.

AB - Purpose: Captopril is known to inhibit the growth of renal cancer but the mechanism involved has been unclear. The current study elucidates the mechanism of captopril induced inhibition of the growth of the Renca mouse renal cancer cell line involving transforming growth factor-β, which is known to be a growth inhibitory cytokine in epithelial cells and tissues. Materials and Methods: Transforming growth factor-β in conditioned medium was measured by bioassay. Levels of transforming growth factor-β and transforming growth factor-β type II receptor expression messenger RNA were determined by reverse transcriptase-polymerase chain reaction and flow cytometry. Cell viability was determined by bromodeoxyuridine (BrdU) incorporation and tetrazolium bromide assay. Results: Captopril (0.01 to 1 mM.) showed no significant effect on transforming growth factor-β synthesis or transforming growth factor-β messenger RNA in Renca cells. On the other hand, 1 mM. captopril significantly inhibited Renca cell growth. Reverse transcriptase-polymerase chain reaction and flow cytometry showed that 1 mM. captopril up-regulated type II receptor expression. Conclusions: These findings suggest that captopril restores transforming growth factor-β type II receptor expression and inhibits the growth of Renca cells by increasing their sensitivity to transforming growth factor-β.

KW - Captopril

KW - Carcinoma

KW - Kidney

KW - Mice

KW - Receptors

KW - Renal cell

KW - Transforming growth factor beta

UR - http://www.scopus.com/inward/record.url?scp=0035190076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035190076&partnerID=8YFLogxK

U2 - 10.1097/00005392-200102000-00083

DO - 10.1097/00005392-200102000-00083

M3 - Article

VL - 165

SP - 616

EP - 620

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 2

ER -